American Society of Clinical Oncology

SHERPA: White

People

  1. Morris
    Morris
  2. Scher
    Scher
  3. Schoder
    Schoder
  4. Fox
    Fox
  5. Danila
    Danila
  6. Fleisher
    Fleisher
  7. Hudis
    Hudis
  8. Jhaveri
    Jhaveri
  9. Rathkopf
    Rathkopf
  10. Slovin
    Slovin

Groups

  1. Department of Medicine (13)
  2. Molecular Imaging and Therapy Service (13)
  3. Radiology, Department of (13)
  4. Solid Tumor Oncology Division (11)
  5. GSK Faculty (10)
  6. Molecular Pharmacology and Chemistry Program Faculty (10)
  7. Sloan Kettering Institute Faculty (10)
  8. Genitourinary Oncology Service (8)
  9. Hematologic Malignancies, Division of (4)
  10. Breast Medicine Service (3)
Search Within
  1. "Molecular Imaging and Therapy Service"
  2. "2011"
Formats
  1. Meeting Abstract (13)
Groups
  1. Department of Medicine (13)
  2. Molecular Imaging and Therapy Service (13)
  3. Radiology, Department of (13)
  4. Solid Tumor Oncology Division (11)
  5. GSK Faculty (10)
  6. Molecular Pharmacology and Chemistry Program Faculty (10)

More Groups

People
  1. Steven Larson (10)
  2. Howard Scher (8)
  3. Michael Morris (8)
  4. Heiko Schoder (5)
  5. Elizabeth Dennis (3)
  6. Josef Fox (3)

More People

Years
  1. 2011 (13)
Publications
  1. Journal of Clinical Oncology (13)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Standardized uptake value (SUV) by positron emission tomography/computed tomography (PET/CT) as a prognostic variable in metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K. L.; Ulaner, G.; Fazio, M.; Eaton, A.; Patil, S.; Evangelista, L.; Serna-Tamayo, C.; McArthur, H. L.; Hudis, C.; Morris, P. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase II study of VEGF trap in patients with radioactive iodine (RAI)-refractory thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Haque, S.; Tuttle, R. M.; Ghossein, R. A.; Schöder, H.; Baum, M. S.; Kelly, K.; Chen, A. P.; Shaha, A. R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody cixutumumab (cix) plus mTOR inhibitor temsirolimus (tem) in metastatic castration-resistant prostate cancer (mCRPC): Results of a phase I pilot study
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Borwick, L. S.; Momen, L.; Curley, T.; Arauz, G.; Larson, S. M.; Fleisher, M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A first-in-human, open-label, phase I/II safety, pharmacokinetic, and proof-of-concept study of ARN-509 in patients with progressive advanced castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Slovin, S. F.; Morris, M. J.; Steinbrecher, J. E.; Chen, Y.; Fleisher, M.; Larson, S. M.; Sawyers, C. L.; Scher, H. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Standardized uptake value (SUV) by positron emission tomography/computed tomography (PET/CT) as a prognostic variable in metastatic breast cancer (MBC)
    Meeting Abstract

    Morris, P. G.; Fazio, M.; Jhaveri, K. L.; Serna-Tamayo, C.; Eaton, A.; Patil, S.; Ulaner, G.; Howard, J.; Larson, S. M.; Hudis, C.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Initial study of bone scan tumor area for early surrogate outcome assessment in patients with metastatic castration-resistant prostate cancer
    Meeting Abstract

    Kim, H. J.; Brown, M. S.; Chu, G. H.; Gjertson, D. W.; Auerbach, M.; Poon, C.; Vidovic, A.; Ramakrishna, B.; Morris, M. J.; Larson, S. M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 ((225)Ac-lintuzumab) (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Ryan, C.; Frattini, M. G.; Cicic, D.; Larson, S. M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • The PCCTC imaging data capture toolset: An analysis of its impact on prostate cancer clinical trial accuracy and workload
    Meeting Abstract

    Dennis, E. R.; Fox, J. J.; Larson, S. M.; Farrelly, J. S.; Schwartz, L. H.; Schöder, H.; Haupt, E. C.; Borwick, L. S.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • FDG-PET in the staging and prognosis of T-cell lymphoma
    Meeting Abstract

    Casulo, C.; Maragulia, J.; Zelenetz, A. D.; Schöder, H.; Feeney, J.; Horwitz, S. M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Initial analytic validation of automated bone scan measures for treatment response assessment in patients with metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Chu, G. H.; Brown, M. S.; Kim, H. J.; Auerbach, M.; Poon, C.; Ramakrishna, B.; Vidovic, A.; Gjertson, D. W.; Morris, M. J.; Larson, S. M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save